Composite tissue allotransplantation
- PMID: 19952701
- DOI: 10.1097/PRS.0b013e3181bf8413
Composite tissue allotransplantation
Abstract
Recently, composite tissue allotransplantation was introduced as a potential clinical treatment for complex reconstructive procedures, including tumor ablative operations, traumatic injuries, and extensive tissue loss secondary to burns. Composite tissue allotransplantations consist of heterogeneous tissues including skin, fat, muscle, nerves, lymph nodes, bone, cartilage, ligaments, and bone marrow, all presenting with different antigenicity. Thus, composite tissue allotransplantations are considered to elicit a stronger response compared with solid organ transplants. This article outlines different experimental models and current clinical applications of composite tissue allotransplantation.
References
-
- Gordon CR, Nazzal J, Lozano-Calderan SA, et al. From experimental rat hindlimb to clinical face composite tissue allotransplantation: Historical background and current status. Microsurgery 2006;26:566–572.
-
- Gorantla V, Maldonado C, Frank J, Barker JH. Composite tissue allotransplantation (CTA): Current status and future insights. Eur J Trauma 2001;27:267–274.
-
- Siemionow M, Ozer K. Advances in composite tissue allograft transplantation as related to the hand and upper extremity. J Hand Surg (Am.) 2002;27:565–580.
-
- Siemionow M, Papay F, Kulahci Y, et al. Coronal-posterior approach for face/scalp flap harvesting in preparation for face transplantation. J Reconstr Microsurg. 2006;22:399–405.
-
- Siemionow M, Bozkurt M, Kulahci Y. Current status of composite tissue allotransplantation. Handchir Mikrochir Plast Chir. 2007;39:145–155.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
